Correlation Between Krystal Biotech and Viking Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Krystal Biotech and Viking Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krystal Biotech and Viking Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Krystal Biotech and Viking Therapeutics, you can compare the effects of market volatilities on Krystal Biotech and Viking Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krystal Biotech with a short position of Viking Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krystal Biotech and Viking Therapeutics.

Diversification Opportunities for Krystal Biotech and Viking Therapeutics

-0.02
  Correlation Coefficient

Good diversification

The 3 months correlation between Krystal and Viking is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Krystal Biotech and Viking Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viking Therapeutics and Krystal Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krystal Biotech are associated (or correlated) with Viking Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viking Therapeutics has no effect on the direction of Krystal Biotech i.e., Krystal Biotech and Viking Therapeutics go up and down completely randomly.

Pair Corralation between Krystal Biotech and Viking Therapeutics

Given the investment horizon of 90 days Krystal Biotech is expected to generate 0.43 times more return on investment than Viking Therapeutics. However, Krystal Biotech is 2.33 times less risky than Viking Therapeutics. It trades about 0.13 of its potential returns per unit of risk. Viking Therapeutics is currently generating about -0.07 per unit of risk. If you would invest  17,275  in Krystal Biotech on August 24, 2024 and sell it today you would earn a total of  1,385  from holding Krystal Biotech or generate 8.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Krystal Biotech  vs.  Viking Therapeutics

 Performance 
       Timeline  
Krystal Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Krystal Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Krystal Biotech is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Viking Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viking Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Krystal Biotech and Viking Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Krystal Biotech and Viking Therapeutics

The main advantage of trading using opposite Krystal Biotech and Viking Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krystal Biotech position performs unexpectedly, Viking Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viking Therapeutics will offset losses from the drop in Viking Therapeutics' long position.
The idea behind Krystal Biotech and Viking Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency